UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal issues, creating a potential buying opportunity. The stock is deeply oversold with an RSI of 15, trading below both the 200-day and 50-day moving averages, indicating capitulation.

UnitedHealth (NYSE:UNH) stock looks attractive - making it a good pick to buy at its current price of around $320.

U.S. equities were mixed at midday, with tech shares and a better-than-expected consumer inflation report lifting the S&P 500 and Nasdaq.

UnitedHealth Group (UNH) stock opened more than 2.5% higher on Wednesday following the previous session's staggering loss of 17.8%. The fallout from the largest private health insurer in the US suspending its guidance as it deals with higher than expected medical costs has sent shivers down the spines of institutional shareholders.

UnitedHealth has faced several headwinds in the recent past, ranging from a cyberattack, which had greater than initially realized impacts, to the tragic killing of its CEO, which caused the company to suffer harsh public backlash over the company's and industry practices.

An analyst reluctantly downgraded UnitedHealth’s stock, as the price plunge and a suspended full-year outlook was just too much to hold a bullish stance.

Key Takeaways UnitedHealth Group shares rebounded modestly after the health insurer on Tuesday pulled its outlook and announced its CEO had stepped down, causing shares to plummet.Analysts from UBS, Oppenheimer,

UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs. Click to read why UNH is a Hold.